Related Experiment Videos
p53 mutations in nonastrocytic human brain tumors
H Ohgaki1, R H Eibl, O D Wiestler
1Division of Neuropathology, University of Zurich, Switzerland.
Cancer Research
|November 15, 1991
Summary
Mutations in the p53 tumor suppressor gene were identified in oligodendrogliomas and medulloblastomas, but not ependymomas. This suggests a potential role for p53 in certain human brain tumors.
Area of Science:
- Neuro-oncology
- Molecular Genetics
- Cancer Biology
Background:
- The p53 tumor suppressor gene plays a critical role in maintaining genomic stability and preventing cancer.
- Alterations in the p53 gene are common in various human cancers, but their role in central nervous system (CNS) neoplasms is not fully understood.
Purpose of the Study:
- To investigate the presence and spectrum of mutations in the p53 gene in primary human brain tumors.
- To determine if p53 mutations correlate with specific types of CNS neoplasms.
Main Methods:
- Genomic DNA was extracted from 51 primary human brain tumors.
- Polymerase chain reaction (PCR) and single-strand conformation polymorphism (SSCP) analysis were used to screen for p53 mutations.
- Direct DNA sequencing was performed to confirm and characterize identified mutations.
Main Results:
- Mutations leading to amino acid changes were detected in 12% of oligodendrogliomas (2/17) and 11% of medulloblastomas (2/19).
- No mutations were found in the 15 ependymomas analyzed.
- Specific mutation sites were identified in exons 5, 6, and 7, with silent mutations also observed.
Conclusions:
- The p53 tumor suppressor gene may play a role in the pathogenesis of certain central nervous system neoplasms, including oligodendrogliomas and medulloblastomas.
- The absence of p53 mutations in ependymomas suggests divergent molecular mechanisms in different brain tumor types.